federal_register: 2021-27521
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts | regulation_id_numbers |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-27521 | Data Standards for Drug and Biological Product Submissions Containing Real-World Data; Draft Guidance for Industry; Availability; Extension of Comment Period | Notice | The Food and Drug Administration (FDA or the Agency) is extending the comment period for the notice of availability entitled "Data Standards for Drug and Biological Product Submissions Containing Real-World Data; Draft Guidance for Industry" that appeared in the Federal Register on October 22, 2021. The Agency is taking this action in response to requests for an extension to allow interested persons additional time to submit comments. | 2021-12-21 | 2021 | 12 | https://www.federalregister.gov/documents/2021/12/21/2021-27521/data-standards-for-drug-and-biological-product-submissions-containing-real-world-data-draft-guidance | https://www.govinfo.gov/content/pkg/FR-2021-12-21/pdf/2021-27521.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA or the Agency) is extending the comment period for the notice of availability entitled "Data Standards for Drug and Biological Product Submissions Containing Real-World Data; Draft Guidance for Industry" that... |